Detection of mcr-1 among Escherichia coli clinical isolates collected worldwide as part of the SENTRY Antimicrobial Surveillance Program in 2014 and 2015

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 9, 2016, Pages 5623-5624

  Castanheira, Mariana ^a   Griffin, Michelle A ^a   Deshpande, Lalitagauri M ^a   Mendes, Rodrigo E ^a   Jones, Ronald N ^a   Flamm, Robert K ^a  

^a JMI LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; AVIBACTAM PLUS CEFTAZIDIME; AZTREONAM; CEFEPIME; CEFTAZIDIME; CEFTOLOZANE PLUS TAZOBACTAM; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DORIPENEM; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; ESCHERICHIA COLI PROTEIN; MCR-1 PROTEIN, E COLI;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIUM ISOLATE; ESCHERICHIA COLI; GEOGRAPHIC DISTRIBUTION; KLEBSIELLA PNEUMONIAE; LETTER; MCR 1 GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI INFECTION; GENETICS; GLOBAL HEALTH; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; SENTINEL SURVEILLANCE;

ANTI-INFECTIVE AGENTS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GLOBAL HEALTH; HUMANS; MICROBIAL SENSITIVITY TESTS; SENTINEL SURVEILLANCE;

EID: 84983353729     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01267-16     Document Type: Letter

References (4)

1. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, Yu LF, Gu D, Ren H, Chen X, Lv L, He D, Zhou H, Liang Z, Liu JH, Shen J. 2016. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16:161-168. http://dx.doi.org/10.1016/S1473-3099(15)00424-7.
2. Clinical and Laboratory Standards Institute. 2015. M07-A10. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 10th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Clinical and Laboratory Standards Institute. 2016. M100-S26. Performance standards for antimicrobial susceptibility testing; 26th informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
4. CTX-M on a novel IncF plasmid: first report of mcr-1 in the United States. Antimicrob Agents Chemother 60:4420-4421. http://dx.doi.org/10.1128/AAC.01103-16.